共 50 条
- [31] New approval: Trabectedin (Yondells®) now for the treatment of ovarian cancer. ONKOLOGIE, 2010, 33 (03): : 130 - 130
- [32] Targeting oxidative phosphorylation as an approach for the treatment of ovarian cancer FRONTIERS IN ONCOLOGY, 2022, 12